GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Petlife Pharmaceuticals Inc (OTCPK:PTLF) » Definitions » Beta

Petlife Pharmaceuticals (Petlife Pharmaceuticals) Beta : 39.14 (As of Jun. 22, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Petlife Pharmaceuticals Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-06-22), Petlife Pharmaceuticals's Beta is 39.14.


Petlife Pharmaceuticals Beta Historical Data

The historical data trend for Petlife Pharmaceuticals's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Petlife Pharmaceuticals Beta Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.12 4.19 -0.45 4.32 4.38

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.23 9.53 4.38 3.77 1.34

Competitive Comparison of Petlife Pharmaceuticals's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Petlife Pharmaceuticals's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Petlife Pharmaceuticals's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Petlife Pharmaceuticals's Beta distribution charts can be found below:

* The bar in red indicates where Petlife Pharmaceuticals's Beta falls into.



Petlife Pharmaceuticals Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Petlife Pharmaceuticals  (OTCPK:PTLF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Petlife Pharmaceuticals Beta Related Terms

Thank you for viewing the detailed overview of Petlife Pharmaceuticals's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Petlife Pharmaceuticals (Petlife Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.
Executives
Randy Steven White director, 10 percent owner, officer: President/Secretary/Treasurer OPLETALOVA 43, PRAGUE 2N 11000

Petlife Pharmaceuticals (Petlife Pharmaceuticals) Headlines